Vascular Graft Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR (2024 - 2029) | 5.70 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Vascular Graft Market Analysis
The Vascular Graft Market is expected to register a CAGR of 5.70% during the forecast period.
Key factors driving market growth include the increasing number of dialysis procedures and rising chronic kidney disease (CKD) cases globally. As per the article published in the journal Kidney International Supplements in April 2022, chronic kidney disease, a progressive condition, affected over 10% of the general population worldwide, accounting for more than 800 million individuals. Moreover, the prevalence of cardiovascular diseases, diabetes, and end-stage renal disease is also expected to drive the market. According to CDC data updated in July 2022, coronary heart disease was the most common type of heart disease, and approximately 20.1 million adults aged 20 and older were diagnosed with the disease in the United States. Since there are more chronic diseases worldwide, there is a need for vascular grafts, which is expected to drive the growth of the market over the next few years.
Moreover, according to data published in April 2022 by the CDC, more than 795,000 people were affected by strokes in the United States each year. About 185,000 of these strokes, or roughly one in four, occurred in people who already had a stroke, and approximately 610,000 of them were first or recurrent strokes. As the number of strokes goes up, the demand for effective treatments like coronary artery by-pass surgery and better cardiovascular devices is expected to increase. This is expected to drive market growth over the forecast period.
Furthermore, an increase in research studies demonstrating the benefits of vascular grafts for various chronic diseases is further likely to propel market growth over the forecast period. For instance, according to an article published by researchers in the United States in January 2023 in the Biofabrication journal, the genipin-crosslinked DAM graft showed improved integrated structure, prolonged stability, proper mechanical properties, and superior biocompatibility. Hence, such research developments are likely to offer significant acceptance for advanced vascular grafts, leading to market growth over the forecast period.
However, in emerging economies, a low rate of reimbursement and rising out-of-pocket costs can slow market growth.
Vascular Graft Market Trends
Kidney Failure Segment is Expected to Witness Growth Over the Forecast Period
The kidney failure segment is expected to witness the fastest growth during the forecast period owing to the increasing number of patients with kidney diseases, end-stage kidney failure, and the availability of procedures using grafts. Kidney Failure is treated by replacing a kidney through a kidney transplant. This process uses vascular grafts. The renal vessel is reconstructed in kidney transplantation using vascular grafts.
For instance, according to the article titled "Kidney Disease Statistics for the United States," published in 2021, nearly 786,000 people in the United States were living with ESRD, with 71% on dialysis and 29% with a kidney transplant. Meanwhile, the number of patients who initiated peritoneal dialysis and who received a preemptive transplant reached an all-time high of 18,631. Additionally, in 2021, a report published by the Kidney Foundation stated that around 4 million people had kidney diseases in Canada, of which 46% of new patients were under 65 years. Moreover, as per the same source, the number of people living with end-stage kidney disease has grown by 35% since 2009. Hence, owing to the rising prevalence of chronic kidney diseases, the market is expected to witness high growth over the forecast period.
Furthermore, in May 2022, the California Institute for Regenerative Medicine (CIRM) awarded UC Davis Professor Aijun Wang a USD 3 million grant to develop a smart, durable vascular device for hemodialysis patients treated for kidney failure. This device uses a unique molecule that guides the body's stem cells to help prevent the failure of synthetic vascular grafts.
Thus, the growing number of people with end-stage kidney failure is likely to increase the demand for vascular grafts, which is expected to help the market grow.
North America is Expected to Retain Largest Market Share Over the Forecast Period
North America dominates the vascular graft market. North America maintained its dominant share due to the high prevalence rates of diabetes, cardiovascular diseases, and chronic kidney diseases. The presence of reimbursement coverage and the availability of state-of-the-art healthcare infrastructure are driving the growth of this market in North America.
The major factor driving the market is the rising burden of various coronary heart diseases, such as stroke and cardiomyopathy, which cause a global burden of cardiac-related deaths. For instance, according to the May 2023 update by the Centers for Disease Control and Prevention, about 0.8 million people in the United States suffered a heart attack. Of these, 0.6 million experienced their first heart attack. Hence, the high prevalence of heart attack cases is likely to favor the utilization of vascular grafts in the country, leading to market growth over the forecast period.
Moreover, as the government ramps up investments and initiatives to advance kidney cancer therapies and diagnostics, the market is poised for growth. Notably, in November 2022, the Kidney Cancer Association (KCA) awarded two grants to researchers from the Fox Chase Cancer Center totaling USD 75,000. These grants aim to support studies that have the potential to enhance kidney cancer treatment and care.
Thus, due to the factors mentioned above, North America is expected to witness market growth over the next few years.
Vascular Graft Industry Overview
The vascular graft market is fairly competitive and consists of several major players. Most of these major players enjoy a global presence, and they are facing intense competition in emerging economies. Key players in the market include Abbott Laboratories, B. Braun Melsungen AG, Bard Peripheral Vascular Inc. (BD), Cardinal Health (Cordis), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc., Medtronic PLC, Terumo Medical Corporation, and W.L. Gore & Associates Inc.
Vascular Graft Market Leaders
-
Abbott Laboratories
-
Cook Medical
-
W.L. Gore & Associates Inc
-
LeMaitre Vascular Inc
-
Terumo Medical Corporation
*Disclaimer: Major Players sorted in no particular order
Recent Developments News
- June 2023: Endologix LLC secured FDA approval for its Detour System, designed to address complex cases of peripheral arterial disease (PAD). The Detour System, utilizing percutaneous transmural arterial bypass (PTAB), offers a novel approach to treating these challenging PAD cases.
- May 2023: Endologix LLC achieved a significant milestone in the JAGUAR randomized controlled trial. The trial assessed the efficacy of Endologix's Alto abdominal stent graft system against other commercially available endovascular aneurysm repair (EVAR) devices for treating abdominal aortic aneurysms.
Vascular Grafts Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumption and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Cardiovascular Disorders
- 4.2.2 Technological Advancements in the Scaffold Material and Design of Vascular Grafts
-
4.3 Market Restraints
- 4.3.1 Unfavorable Reimbursement Scenario
- 4.3.2 High Risk Associated with Graft Failures
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Hemodialysis Access Grafts
- 5.1.2 Endovascular Stent Grafts
- 5.1.3 Peripheral Vascular Grafts
- 5.1.4 Coronary Artery By-pass Grafts
-
5.2 By Application
- 5.2.1 Aneurysms
- 5.2.2 Kidney Failures
- 5.2.3 Vascular Occlusions
- 5.2.4 Coronary Artery Diseases
- 5.2.5 Other Applications
-
5.3 By Raw Material
- 5.3.1 Synthetic Raw Materials
- 5.3.2 Biological Raw Materials
-
5.4 By Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbott Laboratories
- 6.1.2 B. Braun Melsungen AG
- 6.1.3 Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
- 6.1.4 Cardinal Health (Cordis Corporation)
- 6.1.5 Cook Medical
- 6.1.6 Cryolife
- 6.1.7 Getinge Group
- 6.1.8 LeMaitre Vascular Inc.
- 6.1.9 Medtronic PLC
- 6.1.10 Terumo Medical Corporation
- 6.1.11 W.L. Gore & Associates Inc.
- 6.1.12 Endologix Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Vascular Graft Industry Segmentation
As per the scope of the report, vascular grafts are medical devices used in vascular by-pass procedures to direct the blood flow from one area to another by reconnecting the blood vessels.
The vascular graft market is segmented by product, application, raw material and geography. By product, the market is segmented into hemodialysis access grafts, endovascular stent grafts, peripheral vascular grafts, and coronary artery by-pass grafts. By application, the market is segmented into aneurysms, kidney failures, vascular occlusions, coronary artery diseases, and other applications. By raw material, the market is segmented into synthetic raw materials and biological raw materials. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also offers the market size and forecasts for ten countries across the region. For each segment, the market sizing and forecasts have been done on the basis of value (USD).
| By Product | Hemodialysis Access Grafts | |
| Endovascular Stent Grafts | ||
| Peripheral Vascular Grafts | ||
| Coronary Artery By-pass Grafts | ||
| By Application | Aneurysms | |
| Kidney Failures | ||
| Vascular Occlusions | ||
| Coronary Artery Diseases | ||
| Other Applications | ||
| By Raw Material | Synthetic Raw Materials | |
| Biological Raw Materials | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Vascular Grafts Market Research FAQs
What is the current Vascular Graft Market size?
The Vascular Graft Market is projected to register a CAGR of 5.70% during the forecast period (2024-2029)
Who are the key players in Vascular Graft Market?
Abbott Laboratories, Cook Medical, W.L. Gore & Associates Inc, LeMaitre Vascular Inc and Terumo Medical Corporation are the major companies operating in the Vascular Graft Market.
Which is the fastest growing region in Vascular Graft Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Vascular Graft Market?
In 2024, the North America accounts for the largest market share in Vascular Graft Market.
What years does this Vascular Graft Market cover?
The report covers the Vascular Graft Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vascular Graft Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vascular Graft Industry Report
Statistics for the 2024 Vascular Graft market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vascular Graft analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
